FDA Approves Non-Alcohol Cancer Treatment
The Food and Drug Administration (FDA) has approved the Docetaxel Injection, Non-Alcohol Formula, from Teikoku Pharma USA to treat head and neck cancer.
Industry News
Startup Gets $1.5 Million to Develop New Cancer Treatment
The National Cancer Institute has awarded SuviCa Inc. approximately $1.5 million to continue work on new treatments for head and neck cancer. For.
- October 27, 2015
- 1 minute read
Todays Dental News
UC Davis Trains Dogs to Sniff Out Cancer
Someday, your new assistant may have 4 legs and wear a flea collar. Researchers at the University of California, Davis (UC Davis), are.
- September 15, 2015
- 2 minutes read
